MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$10,835,154
EPS
-$2.64
Unit: Dollar

Income Statement
2025-12-31
Total revenue
0
General and administrative
5,745,087
Research and development
10,780,397
Collaboration credits
7,066,237
In-process r&d impairment
4,624,000
Change in fair value of contingent consideration
-1,252,174
Total operating expenses
12,831,073
Operating (loss) income before other income (expense), net
-12,831,073
Impairment of intangible assets
0
Loss on disposal of fixed assets
0
Interest income
894,002
Interest expense
19,960
Other (expense) income, net
-160,272
Total other income, net
713,770
(loss) income before income tax expense
-12,117,303
Income tax benefit (expense)
-1,282,149
Net (loss) income
-10,835,154
Net (loss) income attributable to common shareholders, diluted
-10,835,154
Basic EPS
-2.6
Diluted EPS
-2.64
Basic Average Shares
4,166,692
Diluted Average Shares
4,103,873
Unit: Dollar.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net (loss) incomeattributable to common...-$10,835,154 Net (loss) income-$10,835,154 Income tax benefit(expense)-$1,282,149 Interest income$894,002 (loss) income beforeincome tax expense-$12,117,303 Total other income,net$713,770 Other (expense)income, net-$160,272 Interest expense$19,960 Operating (loss) incomebefore other income...-$12,831,073 Total operatingexpenses$12,831,073 Collaboration credits$7,066,237 Change in fair value ofcontingent consideration-$1,252,174 Research and development$10,780,397 General andadministrative$5,745,087 In-process r&d impairment$4,624,000

KIORA PHARMACEUTICALS INC (KPHMW)

KIORA PHARMACEUTICALS INC (KPHMW)